

- About the disease
- About the test
- Why do I need this test?
- How will I benefit?
- How can I be tested?
- About us
- FAQs
- Glossary
- miRview® home











KNOW, THEN TREAT
miRview® mets and miRview® mets2 are cutting-edge molecular diagnostic tests that leverage
microRNA to accurately identify the tissue-of-origin of tumors,
helping you make informed decisions.
|
miRview® mets2 and miRview® mets accurately identify the tissue-of-origin of tumors Until now, there has been an unmet need for accurate and time-efficient testing to determine primary origin2. miRview® mets is a microRNA-based molecular diagnostic test that identifies the tissue-of-origin of metastatic tumors in both CUP patients and those who are not yet diagnosed. The test offers:
miRview® mets2 and miRview® mets deliver quality results
The miRview® mets assays use quantitative technologies to determine the expression of microRNA in tumor tissue. In the majority of cases, the miRview® mets assays return a single tissue prediction with 90% sensitivity and 99% specificity3. The miRview® mets assays are easy to use
miRview® mets2 and miRview® mets are based on formalin-fixed paraffin-embedded (FFPE) tumor samples, the current standard for preserving tumors in the post-op setting. FFPE samples require minimal preparation to be analyzed by our experts and can be easily shipped via any air courier.
|
